The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome


Sahin Y. , Unluhizarci K. , Yılmazsoy A. , Yıkılmaz A. , Aygen E., Kelestimur F.

CLINICAL ENDOCRINOLOGY, vol.67, no.6, pp.904-908, 2007 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 67 Issue: 6
  • Publication Date: 2007
  • Doi Number: 10.1111/j.1365-2265.2007.02985.x
  • Title of Journal : CLINICAL ENDOCRINOLOGY
  • Page Numbers: pp.904-908

Abstract

Objective There are conflicting data regarding the effects of metformin in lean women with polycystic ovary syndrome (PCOS). Thus, our aim was to evaluate the effects of 6 months of metformin therapy on various metabolic and cardiovascular risk factors in lean women with PCOS.